IdentificationGeneric Name(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOLDrugBank Accession NumberDB08224BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL (DB08224)× CloseWeightAverage: 306.3966 Monoisotopic: 306.18310932 Chemical FormulaC18H26O4SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismULiver carboxylesterase 1Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as delta valerolactones. These are cyclic organic compounds containing an oxan-2- one moiety.KingdomOrganic compoundsSuper ClassOrganoheterocyclic compoundsClassLactonesSub ClassDelta valerolactonesDirect ParentDelta valerolactonesAlternative ParentsOxanes / Secondary alcohols / Carboxylic acid esters / Oxacyclic compounds / Monocarboxylic acids and derivatives / Organic oxides / Hydrocarbon derivatives / Carbonyl compoundsSubstituentsAlcohol / Aliphatic heteropolycyclic compound / Carbonyl group / Carboxylic acid derivative / Carboxylic acid ester / Delta valerolactone / Delta_valerolactone / Hydrocarbon derivative / Monocarboxylic acid or derivatives / Organic oxideMolecular FrameworkAliphatic heteropolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyWWSNTLOVYSRDEL-TVKPWXLESA-NInChIInChI=1S/C18H26O4/c1-11-5-6-12-3-2-4-16(20)18(12)15(11)8-7-14-9-13(19)10-17(21)22-14/h3,5-6,11,13-16,18-20H,2,4,7-10H2,1H3/t11-,13+,14-,15-,16-,18-/m0/s1IUPAC Name(4R,6S)-6-{2-[(1S,2S,8S,8aR)-8-hydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]ethyl}-4-hydroxyoxan-2-oneSMILES[H][C@]1(O)CC(=O)O[C@@]([H])(CC[C@@]2([H])[C@@]([H])(C)C=CC3=CCC[C@]([H])(O)[C@]23[H])C1ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound4369567PubChem Substance99444695ChemSpider3572094ZINCZINC000006416565PDBe LigandMVBPDB Entries1ya8Clinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.26 mg/mLALOGPSlogP1.73ALOGPSlogP1.49ChemaxonlogS-3.1ALOGPSpKa (Strongest Acidic)14.91ChemaxonpKa (Strongest Basic)-0.85ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count3ChemaxonHydrogen Donor Count2ChemaxonPolar Surface Area66.76 Å2ChemaxonRotatable Bond Count3ChemaxonRefractivity85.68 m3·mol-1ChemaxonPolarizability33.96 Å3ChemaxonNumber of Rings3ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9372Blood Brain Barrier+0.7158Caco-2 permeable+0.5949P-glycoprotein substrateSubstrate0.7746P-glycoprotein inhibitor INon-inhibitor0.8898P-glycoprotein inhibitor IINon-inhibitor0.8161Renal organic cation transporterNon-inhibitor0.7553CYP450 2C9 substrateNon-substrate0.8087CYP450 2D6 substrateNon-substrate0.8869CYP450 3A4 substrateSubstrate0.6044CYP450 1A2 substrateNon-inhibitor0.7444CYP450 2C9 inhibitorNon-inhibitor0.9514CYP450 2D6 inhibitorNon-inhibitor0.9062CYP450 2C19 inhibitorNon-inhibitor0.8578CYP450 3A4 inhibitorNon-inhibitor0.6102CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.892Ames testNon AMES toxic0.8148CarcinogenicityNon-carcinogens0.9772BiodegradationNot ready biodegradable0.8487Rat acute toxicity2.6070 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.7194hERG inhibition (predictor II)Non-inhibitor0.7995  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Liver carboxylesterase 1KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionTriglyceride lipase activitySpecific FunctionInvolved in the detoxification of xenobiotics and in the activation of ester and amide prodrugs. Hydrolyzes aromatic and aliphatic esters, but has no catalytic activity toward amides or a fatty acy...Gene NameCES1Uniprot IDP23141Uniprot NameLiver carboxylesterase 1Molecular Weight62520.62 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:29 / Updated at June 12, 2020 16:52 